Gubra AS (CHIX:GUBRAC) Other Current Liabilities: kr55 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:GUBRAC Gubra AS CHIX:GUBRAC
78 GF Score
Price kr354.50
GF Value kr2,853.77
! 3 Warning Signs
View Full Analysis

What is Gubra AS Other Current Liabilities?

Gubra AS CHIX:GUBRAC 78 Other Current Liabilities is kr55 Mil as of Dec. 2025. GuruFocus rates CHIX:GUBRAC with a GF Score™ of 78/100 and a GF Value™ of kr2,853.77. The stock has 3 warning signs investors should review.

Gubra AS's other current liabilities for the quarter that ended in Dec. 2025 was kr55 Mil.

Gubra AS's quarterly other current liabilities increased from Dec. 2024 (kr48 Mil) to Jun. 2025 (kr85 Mil) but then declined from Jun. 2025 (kr85 Mil) to Dec. 2025 (kr55 Mil).

Gubra AS's annual other current liabilities declined from Dec. 2023 (kr62 Mil) to Dec. 2024 (kr48 Mil) but then increased from Dec. 2024 (kr48 Mil) to Dec. 2025 (kr55 Mil).

Gubra AS Other Current Liabilities Related Terms

Gubra AS Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Gubra AS's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gubra AS Other Current Liabilities Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 92.29 70.26 61.93 48.06 55.11

Gubra AS Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 61.93 39.71 48.06 85.15 55.11
CHIX:GUBRAC
78GF Score
Gubra AS CHIX:GUBRAC
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gubra AS Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of kr55 Mil mean?
Gubra AS (CHIX:GUBRAC) has a Other Current Liabilities of kr55 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gubra AS.
Is Gubra AS's Other Current Liabilities too high?
Gubra AS's current Other Current Liabilities is kr55 Mil. Overall, Gubra AS has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's Other Current Liabilities compare to VRTX and REGN?
Gubra AS's Other Current Liabilities of kr55 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gubra AS. Gubra AS's current Other Current Liabilities is kr55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Gubra AS (CHIX:GUBRAC) has a current Other Current Liabilities of kr55 Mil. The stock's GF Value™ is kr2,853.77, compared to a current price of kr354.50 — trading 87.6% below its estimated fair value. The current Other Current Liabilities is kr55 Mil. Gubra AS's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Gubra AS (CHIX:GUBRAC), the current Other Current Liabilities is kr55 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gubra AS (CHIX:GUBRAC) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of kr354.50 is trading 87.6% below its estimated GF Value™ of kr2,853.77.

Key valuation signals for CHIX:GUBRAC:

  • Other Current Liabilities: kr55 Mil
  • GF Value™: kr2,853.77 vs. price of kr354.50 (87.6% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the CHIX:GUBRAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
78GF Score

Get the complete analysis for CHIX:GUBRAC

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr354.50
Price
kr2,853.77
GF Value